1 / 26

West Nile Virus July 12, 2005

West Nile Virus July 12, 2005. Theresa Smith, MD Emily Zielinski-Gutierrez, DrPH Division of Vector Borne Infectious Diseases (DVBID) National Center for Infectious Diseases Centers for Disease Control and Prevention Fort Collins, Colorado. WNV is an Ar thropod- Bo rne virus.

buzz
Download Presentation

West Nile Virus July 12, 2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. West Nile VirusJuly 12, 2005 Theresa Smith, MD Emily Zielinski-Gutierrez, DrPH Division of Vector Borne Infectious Diseases (DVBID) National Center for Infectious Diseases Centers for Disease Control and Prevention Fort Collins, Colorado

  2. WNV is an Arthropod-Borne virus • First discovered in 1937 in the West Nile district of Uganda • Until 1999 only found in Asia, Southern Europe, Africa • Flavivirus, in the Japanese Encephalitis Antigenic Complex –similar family to Yellow Fever, St. Louis encephalitis virus • Transmitted by mosquitoes

  3. WNV: Basic Transmission Cycle Most important cycle is from mosquito to bird to mosquito “Incidental” infections: unlikely amplifying hosts Amplifying hosts

  4. WNV Prevention Based on Transmission • Personal-emphasize at times of high mosquito activity (dawn/dusk) or stay indoors • Use mosquito repellent • Wear long sleeves, pants • Household • Use/ fix screens • Air-conditioning • Empty standing water • Community / environmental • Empty standing water

  5. Repellent Guidance • Skin • DEET still “gold standard” • Both new additions good for shorter term protection • Picaridin • Roughly equivalent to DEET at same concentration • Only a 7% product currently sold in US • Oil of lemon eucalyptus • Plant based • 30% product similar to low concentration DEET • Not for kids <3 years old • Clothing • Permethrin

  6. Transmission • The most common route of infection is bite of infectious mosquito • 2002 revealed other modes • Blood Transfusion • Organ Transplantation • Intrauterine • Percutaneous exposure (occ. exposure) • Breastmilk (probable)

  7. Screening of Blood Supply • As of July 2003, all blood donated in US is screened for WNV using nucleic acid amplification testing (NAT) • Platform under IND • Use of NAT continues to be refined • Transfusion-associated risk very, very low • In 2004, 224 PVDs identified • One transfusion-associated transmission associated with a change in use of NAT

  8. Presumptively Viremic Blood Donors, 2004

  9. Presumptively Viremic Blood Donors, 2005 As of July 5, 2005

  10. WNV and Pregnancy • One confirmed intrauterine WNV infection (2002) • Zero cases of WNV intrauterine transmission detected in 79 pregnancies (2003-4) • Three cases of early post-natal WNV infection • Transplacentally transmitted?

  11. WNV and Pregnancy • Nine major birth defects were detected (12 percent of live births) • Chance occurrences • Phenotypic inconsistency (except microcephaly) • Maternal WNV infection often followed expected timing of defect development • Registry for pregnant women with WNV

  12. WNV Human Infection “Iceberg” For every case of illness involving the brain or spinal cord, ~150 total infections ~10% of CNS ds are fatal (<0.1% of total infections) <1% CNS disease ~20% “West Nile Fever” ~80% Asymptomatic

  13. WNV Fever • Most who get sick from WNV infection have WNV fever • Time from mosquito bite to illness averages 3-5 days • Fever, chills, headache, fatigue can be severe • Nausea, vomiting • Rash, usually not itchy, lasting a few days, mainly on chest, back, abdomen, and/or arms • Usually better within a week, though persistent headache, fatigue common -- reports of weeks, even longer among otherwise healthy persons

  14. WNV Meningitis • Fever, headache, meningismus, photosensitivity • White blood cells in the cerebrospinal fluid • Headache may be quite severe • Most people improve, though persistent headache, fatigue common

  15. WNV Encephalitis • Severity ranges from mild confusion to coma and death • Other symptoms • Tremor • Myoclonus • Dizziness

  16. WNV-Associated Flaccid Paralysis • Recognized more frequently in the last 2 years • Affects relatively healthy young people • May not have fever or headache before paralysis • Clinical hallmarks: • Onset early in infection • Weakness can often be in only one limb • Absence of numbness; pain sometimes present

  17. Risk for Severe Disease • Persons over 50 at higher risk • Solid organ transplant recipients

  18. Diagnosis of WNV Infection • Suspect in meningitis, encephalitis, or flaccid paralysis from summer through fall, or December in the South • Consider other arboviral diseases such as St. Louis encephalitis • Local WNV enzootic activity or other human cases should raise suspicion • Recent travel history also important • State labs can help with diagnostic testing of serum or CSF for WNV IgM and/or IgG

  19. Reporting • Reporting procedures vary by state – Check with state coordinators/state websites • All human WNV illness is reportable as of 2004

  20. WNV Treatment • No specific treatment for WNV disease • 3 IRB-approved, randomized, double-blinded, placebo-controlled clinical trials available

  21. WNV Outcomes • Neuroinvasive disease • 10-20% with severe disease die • Fatalities primarily among elderly, immunosuppressed • WNV flaccid paralysis • Some people with almost complete recovery; others with continued weakness • Those with less severe initial weakness tend to have a better prognosis

  22. Incidence per million .01-9.99 Any WNV Activity 10-99.99 >=100 WNND County Level Incidence per Million, United States, 2004

  23. 2004, WNV Activity (available : http://www.cdc.gov/ncidod/dvbid/westnile/surv&control04Maps.htm)

  24. 2005 WNV Activity, as of 5 July 2005

  25. Info Online • West Nile Virus: Information and Guidance for Clinicians • http://www.cdc.gov/ncidod/dvbid/westnile/clinicians/ • http://www.cdc.gov/ncidod/dvbid/westnile/clinicalTrials.htm • Diagnosis section http://www.cdc.gov/ncidod/dvbid/westnile/resources/fact_sheet_clinician.htm

  26. Registry for Women Infected with WNV while Pregnant • Interim Guidelines for the evaluation of infants born to women infected with WNV during pregnancy. See: http://www.cdc.gov/ncidod/dvbid/westnile/DuringPregnancy/WNV_duringPregnancy.htm

More Related